The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: A mycological perspective

Critical Reviews in Microbiology

Volumn 37, Issue 3, 2011, Pages 250-261

  Ilkit, MacIt ^a   Guzel, Ahmet Baris ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Candida albicans; chromogenic media; immunochromatography; microscopic examination; polyfungal; vaginitis

Indexed keywords

AGAR; CHROMOGENIC SUBSTRATE; SABOURAUD DEXTROSE AGAR; UNCLASSIFIED DRUG;

CANDIDA ALBICANS; CELL ADHESION; CLINICAL FEATURE; DISEASE TRANSMISSION; DNA DETERMINATION; FUNGAL COLONIZATION; FUNGAL STRAIN; FUNGUS CULTURE; IMMUNOAFFINITY CHROMATOGRAPHY; LABORATORY DIAGNOSIS; MICROSCOPY; PATHOGENESIS; PH; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEXUAL TRANSMISSION; VAGINA CANDIDIASIS; VAGINA FLORA; VAGINAL LAVAGE;

CANDIDA; CANDIDIASIS, VULVOVAGINAL; CLINICAL LABORATORY TECHNIQUES; FEMALE; HUMANS; MYCOLOGY;

BACTERIA (MICROORGANISMS); CANDIDA ALBICANS;

EID: 79959755226     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2011.576332     Document Type: Review

References (102)

1. Abbott J. (1995). Clinical and microscopic diagnosis of vaginal yeast infection: a prospective analysis. Ann Emerg Med, 25, 587-91.
2. Achkar JM, Fries BC. (2010). Candida infections of the genitourinary tract. Clin Microbiol Rev, 23, 253-73.
3. Amsel R, Totten PA, Spiegel CA, Chen KCS, Eschenbach DA, Holmes KK. (1983). Nonspecifc vaginitis: diagnostic criteria and epidemiologic association. Am J Med, 74, 14-22. (Pubitemid 13221599)
4. Anderson MR, Klink K, Cohrssen A. (2004). Evaluation of vaginal complaints. JAMA, 291, 1368-79. (Pubitemid 38541652)
5. Anson JJ, Allen KD. (1997). Evaluation of CHROMagar Candida medium for the isolation and direct identifcation of yeast species from the female genitale tract. Br J Biomed Sci, 54, 237-9. (Pubitemid 28025070)
6. Antonio MAD, Hawes SE, Hillier SL. (1990). The identifcation of Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis, 180, 1950-6.
7. Auger P, Joly J. (1980). Microbial fora associated with Candida albicans vulvovaginitis. Obstet Gynecol, 55, 397-401. (Pubitemid 10129723)
8. Babula O, Lazdane G, Kroica J, Ledger WJ, Witkin SS. (2003). Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin Infect Dis, 37, 733-7. (Pubitemid 37100818)
9. Barousse MM, Espinosa T, Dunlap K, Fidel P Jr. (2005). Vaginal epithelial cells anti-Candida albicans activity is associated with protection against symptomatic vaginal candidiasis. Infect Immun, 73, 7765-7. (Pubitemid 41587683)
10. Bergmann JJ, Berg AO, Schneeweiss R, Heidrich FE. (1984). Clinical comparison of microscopic and culture techniques in the diagnosis of Candida vaginitis. J Fam Pract, 18, 549-52. (Pubitemid 14172539)
11. Bouchara JP, Declerck P, Cimon B, Planchenault C, de Gentile L, Chabasse D. (1996). Routine use of CHROMagar Candida medium for presumptive identifcation of Candida yeast species and detection of mixed polyfungal populations. Clin Microbiol Infect, 2, 202-8. (Pubitemid 126682693)
12. Carroll CJ, Hurley J, Stanley VC. (1973). Criteria for diagnosis of Candida vulvovaginitis in pregnant women. J Obstet Gynaecol Br Commonw, 80, 258-63.
13. Casadevall A, Pirofski LA. (1999). Host-pathogen interactions: redefning the basic concepts of virulence and pathogenicity. Infect Immun, 67, 3703-13. (Pubitemid 29356981)
14. Casadevall A, Pirofski LA. (2000). Host pathogen interactions: basic concepts of microbial commensalism, colonisation, infection and disease. Infect Immun, 68, 6511-8.
15. Center for Disease Control,and Prevention, Workowski KA, Berman SM. (2006). Sexually transmitted diseases treament guidelines. MMWR Recomm Rep, 55, 1-94.
16. Chaim W. (1997). Fungal vaginitis caused by non-albicans species. Am J Obstet Gynecol, 177, 485-6. (Pubitemid 27385747)
17. Chatwani AJ, Mehta R, Hassan S, Rahimi S, Jeronis S, Dandolu V. (2007). Rapid testing for vaginal yeast detection: a prospective study. Am J Obstet Gynecol, 196, 309-10.
18. Chong PP, Lee YL, Tan BC, Ng PK. (2003). Genetic relatedness of Candida strains isolated from women with vaginal candidiasis in Malaysia. J Med Microbiol, 52, 657-66. (Pubitemid 36981473)
19. Dan M, Leshem Y, Yeshaya A. (2010). Performance of a rapid yeast in detecting Candida spp. in the vagina. Diagn Microbiol Infect Dis, 67, 52-5.
20. Daniels W, Glover DD, Essmann M, Larsen B. (2001). Candidiasis during pregnancy may result from isogenic commensal strains. Infect Dis Obstet Gynecol, 9, 65-73. (Pubitemid 32666602)
21. Donders GG. (2007). Defnition and classifciation of abnormal vaginal fora. Best Pract Res Clin Obstet Gynaecol, 21, 355-73. (Pubitemid 46838566)
22. Donders GG, van Straeten D, Hooft P, De Wet GH. (1992). Detection of Candida cell forms in Pap smears during pregnancy. Eur J Obstet Gynecol Reprod Biol, 9, 13-8.
23. Dorrell L, Edwards A. (2002). Vulvovaginitis due to fuconazole resistant Candida albicans following self treatment with non-prescribed triazoles. Sex Transm Infect, 78, 308-9.
24. Eckert LO. (2006). Acute vulvovaginitis. New Engl J Med, 355, 1244-52. (Pubitemid 44427448)
25. Eckert LO, Hawse SE, Stevens CE, Koutsky LA, Eschenbach DA, Holmes KK. (1998). Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet Gynecol, 92, 757-65. (Pubitemid 28487670)
26. Eschenbach DA, Davick PR, Williams BL, Klebanof SJ, Young-Smith K, Critchlow CM, Holmes KK. (1989). Prevalence of hydrogen-peroxide producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol, 27, 251-6. (Pubitemid 19041152)
27. Ferris DG, Dekle C, Litaker MS. (1996). Women's use of over-the-counter antifungal medications for gynecologic symptoms. J Fam Pract, 42, 595-600.
28. Fidel PL Jr. (2007). History and update on host defense against vaginal candidiasis. Am J Reprod Immunol, 57, 2-12. (Pubitemid 44911601)
29. Fidel PL Jr, Barousse M, Espinosa T, Ficarra M, Sturvetant J, Martin DH, Quayle AJ, Dunlap K. (2004). An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun,72, 2939-46. (Pubitemid 38542424)
30. Fidel PL Jr, Vazquez JA, Sobel JD. (1999). Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev, 12, 80-96. (Pubitemid 29055954)
31. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. (2000). Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis, 27, 230-5. (Pubitemid 30210802)
32. Freydiére AM, Guinet R, Boiron P. (2001). Yeast identifcation in the clinical microbiology laboratory: phenotypical methods. Med Mycol, 39, 9-33. (Pubitemid 32192914)
33. Geiger AM, Foxman B, Gillespie BW. (1995). The epidemiology of vulvovaginal candidiasis among university students. Am J Public Health, 85, 1146-8.
34. Giraldo PC, Babula O, Gonçalves AK, Linhares IM, Amaral RL, Ledger WJ, Witkin SS. (2007). Mannose-binding lectin gene polymorphism, vulvovaginal candidiasis, and bacterial vaginosis. Obstet Gynecol, 109, 1123-8. (Pubitemid 46685956)
35. Goldacre MJ, Watt B, Loudon N, Milne LJ, Loudon JD, Vessey MP. (1979). Vaginal microbial fora in normal young women. Br Med J, 1, 1450-3. (Pubitemid 9202376)
36. Guzel AB, Ilkit M, Akar T, Burgut R, Demir SC. (2011). Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identifcation of vaginal yeast species. Med Mycol, 49, 16-25.
37. Hillier SL, Krohn MA, Nugent R P, Gibbs RS. (1992). Characteristics of three vaginal fora patterns assessed by Gram stain among pregnant women. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol, 166, 938-44.
38. 2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis, 16, S273-S81.
39. Hopwood V, Evans EGV, Carney JA. (1985). Rapid diagnosis of vaginal candidosis by latex particle agglutination. J Clin Pathol, 38, 455-8. (Pubitemid 15106612)
40. Hospenthal DR, Beckius ML, Floyd KL, Horvath LL, Murray KK. (2006). Presumptive identifcation of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida. Ann Clin Microbiol Antimicrob, 5, 1.
41. Ilkit M, Hilmioglu S, Tasbakan M, Aydemir S. (2007). Evaluation of Albicans ID2 and Biggy agar for the isolation and direct identifcation of vaginal yeast isolates. J Med Microbiol, 56, 762-5. (Pubitemid 46911230)
42. Kwon-Chung KJ, Wickes BL, Salkin IF, Kotz HL, Sobel JD. (1990). Is Candida stellatoidea disappearing from the the vaginal mucosa? J Clin Microbiol, 28, 600-1. (Pubitemid 20078141)
43. Ledger WJ, Polaneczky MM, Yih MC, Jeremias J, Tolbert V, Witkin SS. (2000). Difculties in the diagnosis of Candida vaginitis. Infect Dis Clin Pract, 9, 66-9.
44. Ledger WJ, Witkin SS. (2007). Vulvovaginal Infections. Washington: ASM Press.
45. Lian C, Zhao J, Zhang Z, Liu W. (2004). Genotype of Candida species associated with diferent conditions of vulvovaginal candidosis. Mycoses, 47, 495-502. (Pubitemid 40125547)
46. Lisboa C, Costa AR, Ricardo E, Santos A, Azevedo F, Pina-Vaz C, Rodrigues AG. (2011). Genital candidosis in heterosexual couples. J Eur Acad Dermatol Venereol, 25, 145-51.
47. Lockhart SR, Fritch JJ, Meier SA, Schröppel K, Srikantha T, Galask R, Soll DR. (1995). Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fngerprinting and C1 sequencing. J Clin Microbiol, 33, 1501-9.
48. Lockhart SR, Reed BD, Pierson CL, Soll DR. (1996). Most frequent scenario for recurrent Candida vaginitis is strain maintenance with "substrain shufing": demonstration by sequential DNA fngerprinting with probes Ca3, C1, and CARE2. J Clin Microbiol, 34, 767-77.
49. Lowe NK, Neal JL, Ryan-Wenger NA. (2009). Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard. Obstet Gynecol, 113, 89-95.
50. Macura AB, Voss A, Melchers WJ, Meis JF, Sysło J, Heczko PB. (1998). Characterization of pathogenetic determinants of Candida albicans strains. Zentralbl Bakteriol, 287, 501-8. (Pubitemid 28271152)
51. Mårdh P-A, Rodrigues A, Genc M, Novikova N, Martinez-de-Oliveira J, Guaschino J. (2002). Facts and myths on recurrent vulvovaginal candidiasis: a review of epidemiology, clinical manifestations, diagnosis, pathogenesis, and therapy. Int J STD AIDS, 13, 522-39. (Pubitemid 34816236)
52. Mårdh P-A, Novikova N, Stukolava E. (2003). Colonisation of extragenital sites by Candida in women with recurrent vulvovaginal candidosis. Br J Obstet Gynecol, 110, 934-7. (Pubitemid 37204950)
53. Marot-Leblond A, Nail-Billaud S, Pilon F, Beucher B, Poulain D, Robert R. (2009). Efcient diagnosis of vulvovaginal candidiasis by use of a new rapid immunochromatography. J Clin Microbiol, 47, 3821-5.
54. Martinez RC, Franceschini SA, Patta MC, Quintana SM, Nunes AC, Moreira JL, Anukam KC, Reid G, De Martinis EC. (2008). Analysis of vaginal lactobacilli from healthy and infected Brazilian women. Appl Environ Microbiol, 74, 4539-42. (Pubitemid 352031037)
55. Matsui H, Hanaki H, Takahashi K, Yokoyama A, Nakae T, Sunakawa K, Omura S. (2009). Rapid detection of vaginal Candida species by newly developed immunochromatography test. Clin Vacc Immunol, 16, 1366-8.
56. McClelland RS, Richardson BA, Hassan WM, Graham SM, Kiarie J, Baeten JM, Mandaliya K, Jaoko W, Ndinya-Achola JO, Holmes KK. (2009). Prospective study of vaginal bacterial fora and other risk factors for vulvovaginal candidiasis. J Infect Dis, 199, 1883-90.
57. Mendling W, Pinto de Andrade M, Gutschmidt J, Gantenberg R, Presber W, Schönian G. (2000). Strain specifcity of yeasts isolated from diferent locations of women sufering from vaginal candidosis, and their partners. Mycoses, 43, 387-92. (Pubitemid 32055281)
58. Merson-Davies LA, Odds FC, Malet R, Young S, Riley V, Schober P, Fisk PG. (1991). Quantifcation of Candida albicans morphology in vaginal smears. Eur J Obstet Gynecol Reprod Biol, 42, 49-52.
59. Nickerson WJ. (1953). Reduction of inorganic substances by yeasts. I. Extracellular reduction of sulfte by species of Candida. J Infect Dis, 93, 45-56.
60. Novikova N, Rodrigues A, Mårdh P-A. (2002). Can the diagnosis of recurrent vulvovaginal candidosis be improved by use of vaginal lavage samples and cultures on chromogenic agar? Infect Dis Obstet Gynecol, 10, 89-92.
61. Nugent RP, Krohn MA, Hillier SL. (1991). Reliability of diagnosing bacterial vaginosis is improved by a standard method of Gram stain interpretation. J Clin Microbiol, 29, 297-301.
62. Nyirjesy P, Alexander AB, Weitz MV. (2005). Vaginal Candida parapsilosis: pathogen or bystander? Infect Dis Obstet Gynecol, 13, 37-41. (Pubitemid 40676986)
63. Nyirjesy P, Seeney SM, Grody MHT, Jordan CA, Buckley HR. (1995). Chronic fungal vaginitis: the value of cultures. Am J Obstet Gynecol, 173, 820-3.
64. Nyirjesy P, Sobel JD. (2003). Vulvovaginal candidiasis. Obstet Gynecol Clin North Am, 30, 671-84. (Pubitemid 38018631)
65. Odds FC. (1991). Sabouraud('s) agar. J Med Vet Mycol, 29, 355-9.
66. Odds FC, Bernaerts R. (1994). CHROMagar Candida, a new diferential isolation medium for presumptive identifcation of clinically important Candida species. J Clin Microbiol, 32, 1923-9. (Pubitemid 24222272)
67. Odds FC, Webster CE, Mayuranathan P, Simmons PD. (1988). Candida concentrations in the vagina and their association with signs and symptoms of vaginal candidiasis. J Med Vet Mycol, 26, 277-83. (Pubitemid 19077311)
68. Okungbowa FI, Isikhuemhen OS, Dede AP. (2003). The distribution of frequency of Candida species in the genitourinary tract among symptomatic individuals in Nigerian cities. Rev Iberoam Micol, 20, 60-3. (Pubitemid 37408421)
69. Ozcan K, Ilkit M, Ates A, Turaç-Biçer A, Demirhindi H. (2010). Performance of Chromogenic Candida agar and CHROMagar Candida in recovery and presumptive identifcation of monofungal and polyfungal vaginal isolates. Med Mycol, 48, 29-34.
70. Pagano J, Levine JD, Trejo W. (1957-1958). Diagnostic medium for diferentiation of species of Candida. Antibiot Ann, 5, 137-43.
71. Pappas PG, Kaufmann CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD; Infectious Diseases Society of America. (2009). Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis, 48, 503-35.
72. Pfaller MA, Houston A, Cofmann S. (1996). Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J Clin Microbiol, 34, 58-61. (Pubitemid 126506893)
73. Pike WJ, Clarke J, Lacey CJ, Hunter PA, Evans EG. (1991). Candida cell wall mannan in the vagina and its association with the signs and symptoms of vaginal candidosis. J Med Vet Mycol, 29, 305-12.
74. Pincus DH, Orenga S, Chatellier S. (2007). Yeast identifcation: past, present, and future methods. Med Mycol, 45, 97-121. (Pubitemid 46371953)
75. Pirofski LA, Casadevall LA. (2002). The meaning of microbial exposure, infection, colonisation, and disease in clinical practice. Lancet Infect Dis, 2, 628-35.
76. Redondo-Lopez V, Cook RL, Sobel JD. (1990). Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microfora. Rev Infect Dis, 12, 856-72. (Pubitemid 20349968)
77. Reed BD, Pierson CL. (1992). Evaluation of a latex agglutination test for the identifcation of Candida species in vaginal discharge. J Am Board Fam Pract, 5, 375-80.
78. Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. (2005). Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol, 43, 2155-62. (Pubitemid 40656220)
79. Schwiertz A, Taras D, Rusch K, Rusch V. (2006). Trowing the dice for the diagnosis of vaginal complaints? Ann Clin Microbiol Antimicrob, 5, 4.
80. Siegler SL. (1946). A new method for treatment of vaginitis and cervicitis. Am J Obstet Gynecol, 52, 1-13.
81. Singh S, Sobel JD, Bhargava P, Boikov D, Vazquez JA. (2002). Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy. Clin Infect Dis, 35, 1066-70. (Pubitemid 35239466)
82. Sobel JD. (1985). Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol, 152, 924-35. (Pubitemid 15016406)
83. Sobel JD. (1999). Vulvovaginitis in healthy women. Compr Ter, 25, 335-46.
84. Sobel JD. (2007). Vulvaginal candidosis. Lancet, 369, 1961-71.
85. Sobel JD, Chaim W. (1996). Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis. J Clin Microbiol, 34, 2497-9. (Pubitemid 26307799)
86. Sobel JD, Chaim W. (1997). Treatment of Torulopsis glabrata vaginitis: a retrospective review of boric acid therapy. Clin Infect Dis, 24, 649-52. (Pubitemid 27143559)
87. Sobel JD, Faro AS, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, Reed BD. (1998). Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol, 178, 203-11. (Pubitemid 28124116)
88. Sobel JD, Vazquez JA. (1996). Symptomatic vulvovaginitis due to fuconazole-resistant Candida albicans in a female who was not infected with human immunodefciency virus. Clin Infect Dis, 22, 726-7. (Pubitemid 26286331)
89. Sobel JD, Zervos M, Reed BD, Hooton T, Soper D, Nyirjesy P, Heine MW, Willems J, Panzer H. (2003). Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications. Antimicrob Agents Chemother, 47, 34-8. (Pubitemid 36070338)
90. Soll DR, Galask R, Isley S, Rao T V, Stone D, Hicks J, Schmid J, Mac K, Hanna C. (1989). Switching of Candida albicans during successive episodes of recurrent vaginitis. J Clin Microbiol, 27, 681-90. (Pubitemid 19098105)
91. Spinillo A, Capuzzo E, Gulminetti R, Marone P, Colonna L, Piazzi G. (1997). Prevalence of and risk factors for fungal vaginitis caused by non-albicans species. Am J Obstet Gynecol, 176, 138-41. (Pubitemid 127780762)
92. Stein GE, Sheridan VL, Magee BB, Magee PT. (1991). Use of rDNA restriction fragment length polymorphisms to diferentiate strains of Candida albicans in women with vulvovaginal candidiasis. Diagn Microbiol Infect Dis, 14, 459-64.
93. Tabrizi SN, Pirotta MV, Rudland E, Garland SM. (2006). Detection of Candida species by PCR in self-collected vaginal swabs of women after taking antibiotics. Mycoses, 49, 523-4. (Pubitemid 44511108)
94. Tan SW, Mackay A, Warmington J. (2003). A serologic test for vulvovaginal candidiasis. Int J Gynaecol Obstet, 82, 79-81. (Pubitemid 36808600)
95. Tietz HJ, Hopp M, Schmalreck A, Sterry W, Czaika V. (2001). Candida africana sp. nov., a new human pathogen or a variant of Candida albicans? Mycoses, 44, 437-45. (Pubitemid 34131789)
96. Trama JP, Adelson ME, Raphaelli I, Stemmer SM, Mordechai E. (2005). Detection of Candida species in vaginal samples in a clinical laboratory setting. Infect Dis Obstet Gynecol, 13, 63-7. (Pubitemid 40979011)
97. Vazquez JA, Sobel JD, Demitriou R, Vaihampayan J, Lynch M, Zervos MJ. (1994). Karyotyping of Candida albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis. J Infect Dis, 170, 1566-9. (Pubitemid 24369918)
98. Vermitsky JP, Self MJ, Chadwick SG, Trama JP, Adelson ME, Mordechai E, Gygax SE. (2008). Survey of vaginal-fora Candida species isolates from women of diferent age groups by use of species-specifc PCR detection. J Clin Microbiol, 46, 1501-3. (Pubitemid 351563601)
99. Vitali B, Pugliese C, Biagi E, Candela M, Turroni S, Bellen G, Donders GG, Brigidi P. (2007). Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR. Appl Environ Microbiol, 73, 5731-41. (Pubitemid 47462983)
100. Wenjin Q, Yifu S. (2006). Epidemiological study on vaginal Candida glabrata isolated from pregnant women. Scand J Infect Dis, 48, 49-54. (Pubitemid 43123843)
101. Willinger B, Hillowoth C, Selitsch B, Manaf M. (2001). Performance of Candida ID, a new chromogenic medium for presumptive identifcation of Candida species, in comparison to CHROMagar Candida. J Clin Microbiol, 39, 3793-5. (Pubitemid 32954550)
102. Zhou X, Westman R, Hickey R, Hansmann MA, Kennedy C, Osborn TW, Forney LJ. (2009). Vaginal microbiota of women with frequent vulvovaginal candidiasis. Infect Immun, 77, 4130-5.